Aya Nambu

Aya Nambu

Auto-generated profile, based on publicly available information

Aya Nambu

Program in Cellular and Molecular Medicine, Children's Hospital Boston, Harvard Medical School, Boston, MA 02115, USA

Research Focus & Metrics

Academic Career Length

25Years (2002-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
1 July 2006 in The Journal of Immunology
Verified
Journal Article
Open access
PDF file
YKYutaka Komiyama
Yutaka Komiyama
SNSusumu Nakae
Susumu Nakae
TMTaizo Matsuki
Taizo Matsuki
ANAya Nambu
Aya Nambu
HIHarumichi Ishigame
Harumichi Ishigame
YIYoichiro Iwakura
Yoichiro Iwakura
IL-17 is a proinflammatory cytokine that activates T cells and other immune cells to produce a variety of cytokines, chemokines, and cell adhesion molecules. This cytokine is augmented in the sera and/or tissues of patients with contact dermatitis, asthma, and rheumatoid arthritis. We previously demonstrated that IL-17 is involved in the development of autoimmune arthritis and contact, delayed, and airway hypersensitivity in mice. As the expression of IL-17 is also augmented in multiple sclerosis, we examined the involvement of this cytokine in these diseases using IL-17−/− murine disease models. We found that the development of experimental autoimmune encephalomyelitis (EAE), the rodent model of multiple sclerosis, was significantly suppressed in IL-17−/− mice; these animals exhibited delayed onset, reduced maximum severity scores, ameliorated histological changes, and early recovery. T cell sensitization against myelin oligodendrocyte glycoprotein was reduced in IL-17−/− mice upon sensitization. The major producer of IL-17 upon treatment with myelin digodendrocyte glycopritein was CD4+ T cells rather than CD8+ T cells, and adoptive transfer of IL-17−/− CD4+ T cells inefficiently induced EAE in recipient mice. Notably, IL-17-producing T cells were increased in IFN-γ−/− cells, while IFN-γ-producing cells were increased in IL-17−/− cells, suggesting that IL-17 and IFN-γ mutually regulate IFN-γ and IL-17 production. These observations indicate that IL-17 rather than IFN-γ plays a crucial role in the development of EAE.

1 December 2003 in The Journal of Immunology
Verified
Journal Article
Closed access
PDF file
SNSusumu Nakae
Susumu Nakae
ANAya Nambu
Aya Nambu
KSKatsuko Sudo
Katsuko Sudo
YIYoichiro Iwakura
Yoichiro Iwakura
Interleukin-17 is a T cell-derived proinflammatory cytokine. This cytokine is suspected to be involved in the development of rheumatoid arthritis (RA) because this cytokine expression is augmented in synovial tissues of RA patients. The pathogenic roles of IL-17 in the development of RA, however, still remain to be elucidated. In this study, effects of IL-17 deficiency on collagen-induced arthritis (CIA) model were examined using IL-17-deficient mice (IL-17−/− mice). We found that CIA was markedly suppressed in IL-17−/− mice. IL-17 was responsible for the priming of collagen-specific T cells and collagen-specific IgG2a production. Thus, these observations suggest that IL-17 plays a crucial role in the development of CIA by activating autoantigen-specific cellular and humoral immune responses.

1 January 2009 in Immunity
Verified
Journal Article
Closed access
HIHarumichi Ishigame
Harumichi Ishigame
SKShigeru Kakuta
Shigeru Kakuta
TNTakeshi Nagai
Takeshi Nagai
MKMotohiko Kadoki
Motohiko Kadoki
ANAya Nambu
Aya Nambu
YIYoichiro Iwakura
Yoichiro Iwakura

1 September 2002 in Immunity
Verified
Journal Article
Closed access
SNSusumu Nakae
Susumu Nakae
YKYutaka Komiyama
Yutaka Komiyama
ANAya Nambu
Aya Nambu
KSKatsuko Sudo
Katsuko Sudo
MIMichiko Iwase
Michiko Iwase
YIYoichiro Iwakura
Yoichiro Iwakura

11 October 2010 in Proceedings of the National Academy of Sciences
Verified
Journal Article
Closed access
PDF file
KOKeisuke Oboki
Keisuke Oboki
TOTatsukuni Ohno
Tatsukuni Ohno
NKNaoki Kajiwara
Naoki Kajiwara
KAKen Arae
Ken Arae
HMHideaki Morita
Hideaki Morita
SNSusumu Nakae
Susumu Nakae
IL-33, a member of the IL-1-related cytokines, is considered to be a proallergic cytokine that is especially involved in Th2-type immune responses. Moreover, like IL-1α, IL-33 has been suggested to act as an “alarmin” that amplifies immune responses during tissue injury. In contrast to IL-1, however, the precise roles of IL-33 in those settings are poorly understood. Using IL-1- and IL-33-deficient mice, we found that IL-1, but not IL-33, played a substantial role in induction of T cell-mediated type IV hypersensitivity such as contact and delayed-type hypersensitivity and autoimmune diseases such as experimental autoimmune encephalomyelitis. Most notably, however, IL-33 was important for innate-type mucosal immunity in the lungs and gut. That is, IL-33 was essential for manifestation of T cell-independent protease allergen-induced airway inflammation as well as OVA-induced allergic topical airway inflammation, without affecting acquisition of antigen-specific memory T cells. IL-33 was significantly involved in the development of dextran-induced colitis accompanied by T cell-independent epithelial cell damage, but not in streptozocin-induced diabetes or Con A-induced hepatitis characterized by T cell-mediated apoptotic tissue destruction. In addition, IL-33-deficient mice showed a substantially diminished LPS-induced systemic inflammatory response. These observations indicate that IL-33 is a crucial amplifier of mucosal and systemic innate, rather than acquired, immune responses.

1 July 2015 in Immunity
Verified
Journal Article
Closed access
HMHideaki Morita
Hideaki Morita
KAKen Arae
Ken Arae
HUHirotoshi Unno
Hirotoshi Unno
KMKousuke Miyauchi
Kousuke Miyauchi
STSumika Toyama
Sumika Toyama
SNSusumu Nakae
Susumu Nakae